Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma

NCT00006119 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: hydroxyurea

Sponsor

UNICANCER